164 related articles for article (PubMed ID: 32395377)
1. Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer Patients.
Yang Y; Min A; Lee KH; Ryu HS; Kim TY; Woo GU; Suh KJ; Lee DW; Lee HB; Moon HG; Han W; Park IA; Noh DY; Im SA
J Breast Cancer; 2020 Apr; 23(2):182-193. PubMed ID: 32395377
[TBL] [Abstract][Full Text] [Related]
2. Androgen Receptor in Stage I-II Primary Breast Cancer -Prognostic Value and Distribution in Subgroups.
Niméus E; Folkesson E; Nodin B; Hartman L; Klintman M
Anticancer Res; 2017 Dec; 37(12):6845-6853. PubMed ID: 29187464
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment.
Søreide JA; Lea OA; Varhaug JE; Skarstein A; Kvinnsland S
Eur J Surg Oncol; 1992 Apr; 18(2):112-8. PubMed ID: 1582503
[TBL] [Abstract][Full Text] [Related]
4. The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease Outcome.
Ricciardelli C; Bianco-Miotto T; Jindal S; Butler LM; Leung S; McNeil CM; O'Toole SA; Ebrahimie E; Millar EKA; Sakko AJ; Ruiz AI; Vowler SL; Huntsman DG; Birrell SN; Sutherland RL; Palmieri C; Hickey TE; Tilley WD
Clin Cancer Res; 2018 May; 24(10):2328-2341. PubMed ID: 29514843
[No Abstract] [Full Text] [Related]
5. Androgen receptor expression in a Sri Lankan patient cohort with early breast carcinoma.
Wijesinghe HD; Wijesinghe GK; Mansoor Z; Vigneshwara S; Fernando J; Gunasekera D; Lokuhetty MDS
BMC Womens Health; 2020 Sep; 20(1):206. PubMed ID: 32928183
[TBL] [Abstract][Full Text] [Related]
6. Androgen Receptor as a Predictive Marker for Pathologic Complete Response in Hormone Receptor-Positive and HER-2-Negative Breast Cancer with Neoadjuvant Chemotherapy.
Lee EG; Lee DE; Kim HH; Han JH; Lee S; Kang HS; Lee ES; Chae H; Sim SH; Lee KS; Kwon Y; Jung SY
Cancer Res Treat; 2023 Apr; 55(2):542-550. PubMed ID: 36097802
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of androgen receptor (AR) in HER2-enriched metastatic breast cancer.
Wang X; Bi X; Huang Z; Huang J; Xia W; Shi W; Yuan Z
Endocr Relat Cancer; 2020 Apr; 27(4):199-208. PubMed ID: 31958314
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.
Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F
BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566
[TBL] [Abstract][Full Text] [Related]
9. Role of androgen receptor expression in early stage ER+/PgR-/HER2- breast cancer.
Tagliaferri B; Quaquarini E; Palumbo R; Balletti E; Presti D; Malovini A; Agozzino M; Teragni CM; Terzoni A; Bernardo A; Villani L; Sottotetti F
Ther Adv Med Oncol; 2020; 12():1758835920958355. PubMed ID: 32994808
[TBL] [Abstract][Full Text] [Related]
10. Tumor characteristics and outcome by androgen receptor expression in triple-negative breast cancer patients treated with neo-adjuvant chemotherapy.
Jongen L; Floris G; Wildiers H; Claessens F; Richard F; Laenen A; Desmedt C; Ardui J; Punie K; Smeets A; Berteloot P; Vergote I; Neven P
Breast Cancer Res Treat; 2019 Aug; 176(3):699-708. PubMed ID: 31106385
[TBL] [Abstract][Full Text] [Related]
11. [18F]-fluorodeoxyglucose positron emission tomography can contribute to discriminate patients with poor prognosis in hormone receptor-positive breast cancer.
Ahn SG; Lee M; Jeon TJ; Han K; Lee HM; Lee SA; Ryu YH; Son EJ; Jeong J
PLoS One; 2014; 9(8):e105905. PubMed ID: 25167062
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of predictive and prognostic value of androgen receptor expression in breast cancer subtypes treated with neoadjuvant chemotherapy.
Shi Z; Liu Y; Zhang S; Cai S; Liu X; Meng J; Zhang J
Discov Oncol; 2023 Apr; 14(1):49. PubMed ID: 37099044
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features and androgen receptor expression in triple negative breast cancer at Lagos, Nigeria.
Haruna M; Daramola AO; Awolola NA; Badr NM; Banjo AAF; Shaaban A
Ecancermedicalscience; 2022; 16():1452. PubMed ID: 36405944
[TBL] [Abstract][Full Text] [Related]
14. Abstract PS6-55: The prognostic utility of AR/ER ratio in young women with breast cancer.
Prabhu JS; Korlimarla A; Rajarajan S; Alexander A; Anupama C; Ramesh R; Srinath B; Sridhar TS
Cancer Res; 2021 Feb; 81(4 Suppl):. PubMed ID: 34421401
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor expression identifies patient with favorable outcome in operable triple negative breast cancer.
Hu XQ; Chen WL; Ma HG; Jiang K
Oncotarget; 2017 Aug; 8(34):56364-56374. PubMed ID: 28915596
[TBL] [Abstract][Full Text] [Related]
16. Does androgen receptor have a prognostic role in patients with estrogen/progesterone-negative and c-erbB-2-positive breast cancer?
Arslan C; Isik M; Guler G; Kulac I; Solak M; Turker B; Ozisik Y; Altundag K
Am Surg; 2012 Sep; 78(9):992-9. PubMed ID: 22964210
[TBL] [Abstract][Full Text] [Related]
17. Relationships between androgen receptor expression and clinicopathological parameters in male breast cancer.
Ucak R; Tanik C; Kaya C; Bozkurt E; Kabukcuoglu F
Ann Ital Chir; 2021 Nov; 10():. PubMed ID: 35734806
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer.
Yasui M; Kawahara T; Izumi K; Yao M; Ishiguro Y; Ishiguro H; Uemura H; Miyoshi Y
BMC Cancer; 2019 Apr; 19(1):331. PubMed ID: 30961575
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic significance of androgen receptor expression and discordant receptor status during progression in breast cancer.
Kim EY; Lee KH; Yun JS; Park YL; Park CH; Do SI; Chae SW
Int J Clin Exp Pathol; 2017; 10(7):7929-7939. PubMed ID: 31966643
[TBL] [Abstract][Full Text] [Related]
20. Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer.
Asano Y; Kashiwagi S; Goto W; Tanaka S; Morisaki T; Takashima T; Noda S; Onoda N; Ohsawa M; Hirakawa K; Ohira M
Cancers (Basel); 2017 Jan; 9(1):. PubMed ID: 28067809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
